Chagas disease, also called American trypanosomiasis, is an inflammatory infectious disease caused by the parasite Trypanosoma cruzi. If left untreated, Chagas disease can cause serious heart and digestive problems.
Here are three things to know.
1. The drug, benznidazole, was approved using the FDA’s Accelerated Approval Pathway.
2. The drug displayed efficacy in two separate clinical trials in pediatric patients. In both trials, 55 percent to 60 percent of children treated with benznidazole tested negative for the disease post treatment.
3. Benznidazole is the first FDA-approved Chagas disease treatment in the U.S.
More articles on supply chain:
US Bioservices to pay $13.4M to resolve kickback suit
Samsung widens stake in prescription drug market through partnership with Japanese pharmaceutical company
Patients brace for price of ‘breakthrough’ leukemia drug CTL019
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
